Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.10-$2.68 |
Market Cap | $640.7M |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $41.4M |
Revenue Growth (YoY) | -97.6% |
Gross Profit (12 Mos) | $35.6M |
Diluted EPS | -$0.16 |
News
See moreYahoo Finance • 13 days ago
Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy
Yahoo Finance • last month
Lexicon a new overweight at Cantor on optimism for Inpefa in cardiomyopathy
Yahoo Finance • 2 months ago
Novo Nordisk (CPSE:NOVO B) Reaches LX9851 Obesity Drug Milestone
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |